Table 3.
Overview of filled prescriptions for antiemetic medications in the intervention (N = 103) and control groups (N = 126) as registered in the Norwegian Prescription Database (NorPD) in the 1st (T1) and 2nd trimester (T2)
| Antiemetic medication | Intervention group | Control group | Intervention group | Control group | Use of antiemetic medications during the 2nd trimester | |
|---|---|---|---|---|---|---|
| T1 n (%) | T1 n (%) | T2 n (%) | T2 n (%) | Crude OR (95% CI) | Adjusted OR* (95% CI) | |
| Meclizine | 9 (8.7) | 6 (4.8) | 5 (4.9) | 4 (3.2) | – | – |
| Promethazine | 3 (2.9) | 8 (6.3) | 3 (2.9) | 7 (5.6) | – | – |
| Metoclopramide | 9 (8.7) | 6 (4.8) | 20 (19.4) | 16 (12.7) | – | – |
| Total* | 21 (20.4) | 20 (15.9) | 28 (27.2) | 27 (21.4) | 0.6 (0.3, 1.2) | 0.4 (0.1, 1.4) |
The impact of an early pharmacist consultation on the use of antiemetic medications in the second trimester in the intervention and control groups is presented as crude ORs and adjusted ORs
T1 First trimester, T2 Second trimester, n number of women
*Adjusted for medication use and employment status at baseline